Drug intelligence / Profile preview

Tregocel

Development stage
Unknown
Lead developer
Max Biocare
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Tregocel is a polyherbal nutraceutical dietary supplement formulated to support joint function and alleviate symptoms of mild knee osteoarthritis. It contains a specific combination of curcuminoids and extracts from four medicinal plants: *Harpagophytum procumbens* (Devil's Claw), *Boswellia serrata* (Indian Frankincense), *Apium graveolens* (Celery), and *Zingiber officinale* (Ginger). The supplement is designed to be used as a complementary therapy alongside standard pharmacological treatments. Clinical data from a multicenter, open-label study (NCT03636035) indicated that long-term supplementation with Tregocel significantly improves physical functionality, reduces joint stiffness, and decreases pain levels in patients with symptomatic mild knee osteoarthritis. Its mechanism of action is attributed to the synergistic anti-inflammatory properties of its constituents, which modulate inflammatory pathways including the inhibition of COX-2 and 5-LOX enzymes.

Brand names
Tregocel
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))Eicosanoid synth (Eicosanoid biosynthesis)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Tregocel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tregocel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call